Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Laurie Appleby MS, APRN, BC

Laurie Appleby MS, APRN, BC

Nurse Practitioner, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts

Biographical Sketch:

Laurie Appleby, APRN, BC, is a nurse practitioner with the Lank Center for Genitourinary Oncology at the Dana-Farber Cancer Institute in Boston. She provides direct oncologic care to patients with genitourinary cancers, including symptom management and telephone triage, and participates in the evaluation and management of patients enrolled in research protocols.

She received her nursing diploma from the Faulkner Hospital School of Nursing in Boston, her BSN from Northeastern University in Boston, and her MS in primary care nursing from Simmons College in Boston.

Ms. Appleby has made many presentations at seminars and symposia on the care of patients with renal cell carcinoma and management of side effects of targeted therapies. Her publications include: Management of Treatment Related Toxicity With Targeted Therapies for Renal Cell Carcinoma: Evidence Based Practice and Best Practices. (Hematol Oncol Clin North Am. 2011;25[4]:893-915).

Ms. Appleby is a member of the Oncology Nursing Society, the Nurse Advisory Board of the Kidney Cancer Association, and the Educational Program Advisory Committee (EPAC) of the National Comprehensive Cancer Network (NCCN).

Positions:

Nurse Practitioner, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts

Degrees:

BSN: Northeastern University, Boston, Massachusetts

MS (primary care nursing): Simmons College, Boston, Massachusetts

Recent Contributions to PracticeUpdate:

  1. ASCO 2016: Laurie Appleby’s Abstract Recommendations—Renal Cell Carcinoma
  2. Neurological, Respiratory, Musculoskeletal, Cardiac, and Ocular Side-Effects of Anti-PD-1 Therapy
  3. Managing the Side Effects Associated With Immune Checkpoint Inhibitors in the Treatment of RCC
  4. Fatigue, Mucositis, Hand–Foot Syndrome, and Dysgeusia in Treatment of Advanced Renal Cell Carcinoma
  5. 2015 Top Stories in Renal Cell Carcinoma: Immunotherapy
  6. Cardiovascular Toxicities in RCC
  7. IKCS 2015: How High Is Too High? Dose-Escalation Schemas in Patients With mRCC
  8. IKCS 2015: mRCC Tumor Burden Reduced With TKI Dose Escalation
  9. Cardiovascular Toxicity After Sorafenib or Sunitinib Therapy in Older Patients With Advanced Renal Cell Carcinoma
  10. ECC 2015: Recommendations From Laurie Appleby, APRN, BC

Recently Updated